BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 30134255)

  • 1. Diagnostic Immunohistochemistry for Soft Tissue and Bone Tumors: An Update.
    Schaefer IM; Hornick JL
    Adv Anat Pathol; 2018 Nov; 25(6):400-412. PubMed ID: 30134255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
    Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
    Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pathologic diagnosis of bone and soft tissue tumors: update].
    Nojima T
    Rinsho Byori; 2014 Jun; 62(6):578-85. PubMed ID: 25151777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
    Fanburg-Smith JC; Smith JD; Flemming DJ
    Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue-a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study.
    Pradhan D; Schoedel K; McGough RL; Ranganathan S; Rao UNM
    Hum Pathol; 2018 Jan; 71():126-134. PubMed ID: 29104110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Entities and New Diagnostic Markers for Head and Neck Soft Tissue and Bone Tumors.
    Franchi A; Thompson LDR; Hernandez-Prera JC; Agaimy A; Williams MD; Mikkelsen LH; Bishop JA; Willems SM; Hellquist H; Ferlito A
    Adv Anat Pathol; 2021 May; 28(3):139-149. PubMed ID: 33559990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics.
    Parrack PH; Mariño-Enríquez A; Fletcher CDM; Hornick JL; Papke DJ
    Am J Surg Pathol; 2023 Apr; 47(4):453-460. PubMed ID: 36693363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2020 WHO Classification: What's New in Soft Tissue Tumor Pathology?
    Kallen ME; Hornick JL
    Am J Surg Pathol; 2021 Jan; 45(1):e1-e23. PubMed ID: 32796172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fusion-related round and spindle cell sarcomas of the bone (beyond Ewing)].
    Vanhersecke L; Linck PA; Le Loarer F
    Ann Pathol; 2022 Apr; 42(3):227-241. PubMed ID: 35216845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New molecular entities of soft tissue and bone tumors.
    Lam SW; Silva TM; Bovée JVMG
    Curr Opin Oncol; 2022 Jul; 34(4):354-361. PubMed ID: 35730501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important Recently Characterized Non-Ewing Small Round Cell Tumors.
    Carter CS; Patel RM
    Surg Pathol Clin; 2019 Mar; 12(1):191-215. PubMed ID: 30709443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A contemporary review of myxoid adipocytic tumors.
    Creytens D
    Semin Diagn Pathol; 2019 Mar; 36(2):129-141. PubMed ID: 30853315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
    Hung YP; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis.
    Thway K; Fisher C
    Semin Diagn Pathol; 2021 Nov; 38(6):170-186. PubMed ID: 34602314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial mesenchymal tumours expressing epithelial markers on immunohistochemistry: Diagnostic clues and pitfalls.
    Andrei V; Haefliger S; Baumhoer D
    Semin Diagn Pathol; 2023 Jul; 40(4):238-245. PubMed ID: 37147159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fluorescence in situ hybridization for the diagnosis of soft-tissue and bone tumors].
    Bertram S; Schildhaus HU
    Pathologe; 2020 Nov; 41(6):589-605. PubMed ID: 32965532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ewing/PNET sarcoma family of tumors: towards a new paradigm?].
    Renard C; Ranchère-Vince D
    Ann Pathol; 2015 Jan; 35(1):86-97. PubMed ID: 25534668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma.
    Puls F; Niblett A; Marland G; Gaston CL; Douis H; Mangham DC; Sumathi VP; Kindblom LG
    Am J Surg Pathol; 2014 Oct; 38(10):1307-18. PubMed ID: 24805859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.